|
|
|
|
LEADER |
00000cam a22000002c 4500 |
001 |
1840048492 |
003 |
DE-627 |
005 |
20230325055104.0 |
007 |
cr uuu---uuuuu |
008 |
230324s1993 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.3886/ICPSR09833.v5
|2 doi
|
035 |
|
|
|a (DE-627)1840048492
|
035 |
|
|
|a (DE-599)KXP1840048492
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
041 |
|
|
|a eng
|
084 |
|
|
|a 2,1
|2 ssgn
|
110 |
2 |
|
|a United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
|e VerfasserIn
|4 aut
|
245 |
1 |
0 |
|a National Household Survey on Drug Abuse, 1990
|
264 |
|
1 |
|a [Erscheinungsort nicht ermittelbar]
|b [Verlag nicht ermittelbar]
|c 1993
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
520 |
|
|
|a This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
|
540 |
|
|
|a ICPSR Terms of Use
|
650 |
|
4 |
|a Alcohol abuse
|
650 |
|
4 |
|a Alcohol consumption
|
650 |
|
4 |
|a amphetamines
|
650 |
|
4 |
|a barbiturates
|
650 |
|
4 |
|a Cocaine
|
650 |
|
4 |
|a Drug Abuse
|
650 |
|
4 |
|a Drug use
|
650 |
|
4 |
|a Drugs
|
650 |
|
4 |
|a Hallucinogens
|
650 |
|
4 |
|a Heroin
|
650 |
|
4 |
|a Households
|
650 |
|
4 |
|a inhalants
|
650 |
|
4 |
|a Marijuana
|
650 |
|
4 |
|a Methamphetamine
|
650 |
|
4 |
|a Prescription Drugs
|
650 |
|
4 |
|a sedatives
|
650 |
|
4 |
|a Smoking
|
650 |
|
4 |
|a stimulants
|
650 |
|
4 |
|a Substance Abuse
|
650 |
|
4 |
|a Substance Abuse Treatment
|
650 |
|
4 |
|a Tobacco use
|
650 |
|
4 |
|a tranquilizers
|
650 |
|
4 |
|a Youths
|
655 |
|
7 |
|a Forschungsdaten
|0 (DE-588)1098579690
|0 (DE-627)857755366
|0 (DE-576)469182156
|2 gnd-content
|
856 |
4 |
0 |
|u https://doi.org/10.3886/ICPSR09833.v5
|x Resolving-System
|z kostenfrei
|3 Volltext
|
935 |
|
|
|a mkri
|
951 |
|
|
|a BO
|
ELC |
|
|
|a 1
|
LOK |
|
|
|0 000 xxxxxcx a22 zn 4500
|
LOK |
|
|
|0 001 4296795872
|
LOK |
|
|
|0 003 DE-627
|
LOK |
|
|
|0 004 1840048492
|
LOK |
|
|
|0 005 20230324125207
|
LOK |
|
|
|0 008 230324||||||||||||||||ger|||||||
|
LOK |
|
|
|0 035
|a (DE-2619)ICPSR9833
|
LOK |
|
|
|0 040
|a DE-2619
|c DE-627
|d DE-2619
|
LOK |
|
|
|0 092
|o n
|
LOK |
|
|
|0 852
|a DE-2619
|
LOK |
|
|
|0 852 1
|9 00
|
LOK |
|
|
|0 935
|a foda
|a nacj
|
OAS |
|
|
|a 1
|
ORI |
|
|
|a SA-MARC-krimdoka001.raw
|